Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMERI.L Regulatory News (MERI)

  • There is currently no data for MERI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV Announcement and Portfolio Update

5 Mar 2019 07:00

RNS Number : 7893R
Merian Chrysalis Investment Co. Ltd
05 March 2019
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the United Kingdom and the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

Merian Chrysalis Investment Company Limited

5 March 2019

 

For immediate release

 

Merian Chrysalis Investment Company Limited (the "Company")

 

NAV Announcement and Portfolio Update

 

 

Net Asset Value

The Company announces that as at 31 December 2018 the unaudited net asset value ("NAV") per ordinary share was 98.54 pence.

 

The above NAV calculation is based on the Company's issued share capital of 100,000,000 ordinary shares of no par value.

 

Update on portfolio compositionSince the Company's admission to the premium segment of the Official List and to trading on the London Stock Exchange's Main Market in November 2018 ("Admission"), the Company has deployed approximately 85 per cent of the net proceeds of the initial issue in the following investments:

 

TransferWise

TransferWise was founded with the aim of reducing fees associated with sending money across borders. With a simple money transfer platform and borderless accounts, TransferWise makes it quick and easy for individuals that travel, live and work internationally to manage their money. Businesses can use TransferWise to pay suppliers or employees overseas, request payments from customers and transfer funds between their own accounts in different countries. Over four million people use TransferWise to transfer over £3 billion every month, saving themselves over £3 million every day.

 

The Company invested approximately US$22 million in TransferWise on Admission.

 

Secret Escapes

Secret Escapes is a members-only online travel company. Its digital marketplace uses innovative technology to connect travellers with discounts on luxury hotels and travel experiences. It helps hotels minimise unsold inventory by allowing them to discreetly market to its members who are seeking luxury travel at affordable prices. The firm operates in many countries around the world and is the market-leading membership based travel company in the UK, Germany, Poland, Czech Republic, Slovakia and the Nordics.

 

The Company invested approximately £13 million in Secret Escapes on Admission.

 

The Hut Group

The Hut Group is an ecommerce business that operates a highly scalable, end-to-end proprietary technology platform powering sales of its own and third-party brands online. The firm has invested significantly in its infrastructure, technology platform and brands and is one of the world's largest online beauty and wellbeing businesses.

 

In December 2018, the Company announced an investment of approximately £9.5 million in The Hut Group.

 

Graphcore

Graphcore is a leading artificial intelligence processor business, which has developed the Intelligence Processing Unit ("IPU") and the related Poplar® graph software toolchain. The IPU is a processor that has been designed from the ground up for machine intelligence applications and supports the training and inference of deep learning models, as well as other machine learning approaches. Based in Bristol, Graphcore's products can improve the efficiency and performance of artificial intelligence applications by between 10 to 100 times, compared to existing hardware solutions.

 

The Company invested approximately US$25 million in a $200 million series D funding round conducted in December 2018.

 

Growth Street

Growth Street has developed an innovative peer-to-peer (P2P) product specifically targeted at UK SMEs. The firm's proprietary technology platform integrates with a number of data sources to provide unmatched speed, flexibility and credit monitoring for SMEs. Growth Street reconciles accounting, bank and credit data on a daily basis which enables it to streamline the credit decision process and provide ongoing credit monitoring and credit line adjustment. Its flagship business finance facility, GrowthLine, is a highly flexible revolving line of credit designed to replace and extend bank overdrafts and invoice financing. Growth Street has facilitated more than £80 million of borrowing since launching in 2014.

 

The Company invested approximately £5 million in a funding round conducted in January 2019.

 

Starling Bank

Starling Bank is a digital challenger bank which has built a scalable platform that delivers a range of financial services. Core products include bank accounts for both retail and SME customers, which allow users to bank via a mobile app, offering digital sign-up, instant notification of transactions insights into spending habits and 24/7 support.

 

In February 2019 the Company committed to invest approximately £19 million in a £60 million series C funding round, subject to regulatory approval (since received) and customary closing conditions. The Company later noted that Starling Bank was awarded a £100 million grant from the Capability and Innovation Fund.

 

Revenue growth

 

The weighted average revenue growth rate in 2018 of the companies within the portfolio was in excess of 50 per cent over 2017.

 

Pipeline

The Company has a strong and growing pipeline of investment opportunities across a range of sectors. Accordingly, the Company intends to raise additional capital in the near future.

 

 

Richard Watts, co-fund manager comments:

 

 "We are delighted that the majority of the proceeds from initial issue have been deployed within four months of Admission. We believe this demonstrates that our team's scale and strong presence in the listed equity market has made the Company highly attractive to later stage, private businesses that recognise the benefit of a long-term supportive investor. We continue to explore a range of exciting investment opportunities. "

 

-End-

 

 

For further information, please contact: Merian Global Investors:

Amelie Shepherd

 

 

+44 (0) 20 7332 7500

Liberum:

Gillian Martin / Christopher Britton

 

+44 (0) 20 3829 5000

Maitland Administration (Guernsey) Limited:

Aimee Gontier / Elaine Smeja

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.merian.com/chrysalis/.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUBPWUPBGAC
Date   Source Headline
18th Dec 202012:18 pmRNSResults of Extraordinary General Meeting
17th Dec 20204:38 pmRNSDirector Declaration
11th Dec 20207:00 amRNSNet Asset Value(s)
27th Nov 20203:03 pmRNSDirector/PDMR Shareholding
27th Nov 20203:02 pmRNSDirector/PDMR Shareholding
25th Nov 20203:38 pmRNSProposed Change of Name
8th Oct 20204:23 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSResults of Capital Raise
6th Oct 202011:20 amRNSUpdate on Placing
1st Oct 20207:00 amRNSPortfolio Update
28th Sep 202010:07 amRNSPrimaryBid.com Offer
28th Sep 202010:00 amRNSProposed Placing of Equity
22nd Sep 20205:05 pmRNSHolding(s) in Company
16th Sep 20209:11 amRNSPortfolio Update
15th Sep 20208:58 amRNSPortfolio Update
11th Sep 20207:00 amRNSPortfolio Update
10th Sep 20204:41 pmRNSSecond Price Monitoring Extn
10th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Sep 202012:07 pmRNSSecond Price Monitoring Extn
10th Sep 202012:02 pmRNSPrice Monitoring Extension
8th Sep 202012:07 pmRNSSecond Price Monitoring Extn
8th Sep 202012:02 pmRNSPrice Monitoring Extension
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSNet Asset Value(s)
29th Jul 20207:00 amRNSPortfolio Update
20th Jul 20207:00 amRNSPortfolio Update
6th Jul 202012:31 pmRNSHolding(s) in Company
6th Jul 202012:28 pmRNSHolding(s) in Company
26th Jun 20207:00 amRNSInterim Accounts to 31 March 2020
23rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
23rd Jun 202012:02 pmRNSPrice Monitoring Extension
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSQuarterly NAV and COVID-19 Portfolio Update
13th May 202012:07 pmRNSSecond Price Monitoring Extn
13th May 202012:02 pmRNSPrice Monitoring Extension
13th May 20207:00 amRNSPortfolio Update
7th May 20204:40 pmRNSSecond Price Monitoring Extn
7th May 20204:35 pmRNSPrice Monitoring Extension
6th May 202012:08 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
30th Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 202012:08 pmRNSSecond Price Monitoring Extn
15th Apr 202012:02 pmRNSPrice Monitoring Extension
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:03 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSStatement relating to COVID-19
20th Mar 20204:46 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.